A detailed history of Pier Capital, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Pier Capital, LLC holds 475,852 shares of MRVI stock, worth $2.66 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
475,852
Previous 478,355 0.52%
Holding current value
$2.66 Million
Previous $3.43 Million 15.45%
% of portfolio
0.59%
Previous 0.53%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$6.84 - $9.73 $17,120 - $24,354
-2,503 Reduced 0.52%
475,852 $3.95 Million
Q2 2024

Aug 07, 2024

SELL
$6.87 - $11.34 $191,947 - $316,839
-27,940 Reduced 5.52%
478,355 $3.43 Million
Q1 2024

May 02, 2024

BUY
$5.11 - $8.76 $1.12 Million - $1.92 Million
219,446 Added 76.5%
506,295 $4.39 Million
Q4 2023

Feb 15, 2024

SELL
$4.7 - $9.87 $17,455 - $36,657
-3,714 Reduced 1.28%
286,849 $1.88 Million
Q3 2023

Nov 14, 2023

SELL
$9.14 - $12.85 $50,151 - $70,507
-5,487 Reduced 1.85%
290,563 $2.91 Million
Q2 2023

Aug 14, 2023

SELL
$12.09 - $15.0 $64,052 - $79,470
-5,298 Reduced 1.76%
296,050 $3.68 Million
Q1 2023

May 10, 2023

BUY
$12.99 - $16.48 $379,217 - $481,100
29,193 Added 10.73%
301,348 $4.22 Million
Q4 2022

Feb 15, 2023

BUY
$12.5 - $24.78 $3.18 Million - $6.3 Million
254,314 Added 1425.45%
272,155 $3.89 Million
Q3 2022

Nov 15, 2022

SELL
$20.6 - $30.37 $283,971 - $418,650
-13,785 Reduced 43.59%
17,841 $455,000
Q2 2022

Aug 15, 2022

BUY
$26.05 - $37.48 $318,956 - $458,905
12,244 Added 63.17%
31,626 $898,000
Q1 2022

May 10, 2022

BUY
$24.46 - $40.92 $220,482 - $368,852
9,014 Added 86.94%
19,382 $684,000
Q4 2021

Feb 10, 2022

BUY
$35.0 - $45.94 $362,880 - $476,305
10,368 New
10,368 $434,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $734M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.